These findings may apparently suggest that two different signaling pathways should be alternatively activated via HGF or via CXCL12, after CLL cells cross-talk with osteoblasts or with fibroblasts, respectively [21]. The gene discussed is HGF; the disease is B-cell chronic lymphocytic leukemia.